European Archives - Page 904 of 981 - European Medical Journal

EMJ

Introducing biomarkers for the management of patients with prostate cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Eleni Efstathiou, MD, PhD, of The University of Texas MD Anderson Cancer Center…

EMJ

CALGB 49907 trial: Standard chemotherapy versus capecitabine for older women with breast cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hyman Muss, MD, of the University of North Carolina, Chapel Hill, NC, provides…

EMJ

Developing targeted therapies for melanoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Georgina Long, BSc, PhD, MBBS, FRACP, of the University of Sydney, Sydney…

EMJ

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Foster City, CA, August 20, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the company’s Marketing Authorization Application (MAA)…

EMJ

More Reliable Prostate Cancer Diagnoses Provided by Sensor Chip

PROSTATE cancer (PrC) diagnosis may become more efficient and reliable thanks to a new sensor chip, according to recent study data.

EMJ

Disabling Ability of Lymphoma to Escape Immune Response May Trigger New Treatments

RESTORING the power of natural killer (NK) cells in the vicinity of lymphoma tumours may catalyse the development of new therapies, according to…

Bruce Culleton: The Latest Developments in Home Dialysis

An interview with Dr Bruce Culleton discussing HOMECHOICE CLARIA, SHARESOURCE and VIVIA at ERA-EDTA 2015.

EMJ

Predicting late recurrence of breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Eleftherios P. Mamounas, MD, of University of Florida Health Cancer Center-Orlando…

EMJ

The management of breast cancer in the Japanese population

At the 14th St. Gallen International Breast Cancer Conference 2015, Masakazu Toi, MD, PhD, of Kyoto University, Japan, explains that there are still only…

New therapeutic approaches for Hodgkin lymphoma

At the 20th Congress of the European Hematology Association (EHA), Andrew Davies, BSc (Hons), BM (Hons), MRCP, PhD, of the University of Southampton…